Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles (Q33407265)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56542223)
(Q57156310)
(Q42388605)
(Q42165364)
(Q38803238)
(Q110165834)
(Q89467453)
(Q96142112)
(P304) 1817-1826
(P407) (Q1860)
(P433) 9880
(P478) 381
(P577) Monday, April 22, 2013
(P921) (Q18936)
(Q1138590)
(Q55785695)
(Q412323)
(P1433) (Q939416)
(P1476) "Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles" (language: en)
(P2093) Andrew Jack
Paul Smith
Christopher Pocock
Andrew McMillan
John Davies
Deborah Turner
Anton Kruger
Joanna Gambell
(P2860) (Q28279668)
(Q28297805)
(Q43143098)
(Q44796944)
(Q34626097)
(Q44776010)
(Q46402373)
(Q44550481)
(Q43864036)
(Q34184706)
(Q40318856)
(Q34742742)
(Q34566901)
(Q28204313)
(Q43055328)
(Q33773306)
(Q53235017)
(Q37334956)
(Q43073127)
(Q55055249)
(Q53202995)
(Q24646379)
(Q46537889)
(Q43286752)
(Q37351043)
(Q53143775)
(Q50495776)
(Q44875676)
(Q28302107)
(Q27860529)
other details
description scientific article

External Links